Search results for " Androgen"

showing 10 items of 75 documents

Autologous Platelet-Rich Plasma in the treatment of androgenetic alopecia: results of a 54-patient prospective study

2021

The current medical treatments of androgenetic alopecia (AGA) have hardly achieved a satisfying clinical improvement. Biologic regenerative therapies, such as platelet-rich plasma (PRP) injections in the scalp, have been proposed recently. This multidisciplinary prospective study aims to explore the efficacy and safety of autologous PRP injections into the scalp of patients with AGA. Fifty-four patients with AGA (35 men and 19 women) were enrolled. Non-activated autologous PRP was injected into the androgen-related areas of the scalp. The study protocol consisted of three sessions of injections at 3-month interval. The effects were assessed by means of noninvasive methods. Safety profile, p…

MalePlatelet-Rich Plasma Autologous PRP Androgenetic Alopecia Woman AGA Man AGA Growth FactorScalpTreatment OutcomePlatelet-Rich PlasmaSettore MED/35 - Malattie Cutanee E VenereeHumansAlopeciaFemaleProspective StudiesHair
researchProduct

Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues

2008

Predictive quantitative structure-activity relationship (QSAR) models of anabolic and androgenic activities for the testosterone and dihydrotestosterone steroid analogues were obtained by means of multiple linear regression using quantum and physicochemical molecular descriptors (MD) as well as a genetic algorithm for the selection of the best subset of variables. Quantitative models found for describing the anabolic (androgenic) activity are significant from a statistical point of view: R2 of 0.84 (0.72 and 0.70). A leave-one-out cross-validation procedure revealed that the regression models had a fairly good predictability [q2 of 0.80 (0.60 and 0.59)]. In addition, other QSAR models were …

MaleQuantitative structure–activity relationshipAnabolismStereochemistrymedicine.medical_treatmentClinical BiochemistryAnabolic and androgenic activitiesQSAR modelQuantitative Structure-Activity RelationshipPharmaceutical ScienceBiochemistrySteroidAnabolic AgentsMolecular descriptorDrug DiscoveryLinear regressionmedicineCluster AnalysisHumansComputer SimulationTestosteroneMolecular BiologyChemistryOrganic ChemistryDihydrotestosteroneModels ChemicalGenetic algorithmDihydrotestosteroneAndrogensQuantum and physicochemical molecular descriptorMolecular MedicineTestosterone and dihydrotestosterone steroid analoguesAlgorithmsAnabolic steroidApplicability domainmedicine.drugBioorganic and Medicinal Chemistry 16: 6448-6459 (2008)
researchProduct

Sex hormones and risk of liver tumor.

2007

The liver is morphologically and functionally modulated by sex hormones. Long-term use of oral contraceptives (OCs) and anabolic androgenic steroids (AASs) can induce both benign (hemangioma, adenoma, and focal nodular hyperplasia [FNH]) and malignant (hepatocellular carcinoma [HCC]) hepatocellular tumors. Hepatic adenomas (HAs) are rare, benign neoplasms usually occurring in young women, the development and the complications of which have been related to the strength of OCs and the duration of their use. HA incidence has fallen since the introduction of pills containing smaller amounts of estrogens. FNH is a benign lesion, most commonly seen in young women, which is thought to represent a …

MaleRiskmedicine.medical_specialtyCirrhosisLiver tumorAdenomamedicine.drug_classPhysiologyBiologyGeneral Biochemistry Genetics and Molecular BiologyAndrogenAromataseHistory and Philosophy of ScienceInternal medicinemedicineHumansSex RatioHCCGonadal Steroid HormonesHepatitisGeneral NeuroscienceLiver NeoplasmsFocal nodular hyperplasiaCancermedicine.diseaseEstrogenEndocrinologyLiverReceptors EstrogenEstrogenReceptors AndrogenHepatocellular carcinomaFemaleBenign liver tumorAnnals of the New York Academy of Sciences
researchProduct

Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines.

2009

International audience; Glyphosate-based herbicides are the most widely used across the world; they are commercialized in different formulations. Their residues are frequent pollutants in the environment. In addition, these herbicides are spread on most eaten transgenic plants, modified to tolerate high levels of these compounds in their cells. Up to 400 ppm of their residues are accepted in some feed. We exposed human liver HepG2 cells, a well-known model to study xenobiotic toxicity, to four different formulations and to glyphosate, which is usually tested alone in chronic in vivo regulatory studies. We measured cytotoxicity with three assays (Alamar Blue (R), MTT ToxiLight (R)), plus gen…

MaleTranscription GeneticEstrogen receptor010501 environmental sciencesEndocrine DisruptorsToxicologymedicine.disease_cause01 natural scienceschemistry.chemical_compoundGenes ReporterAromataseCytotoxicityendocrine disruptor0303 health sciencesroundupsexual steroidsEndocrine disruptorBiochemistryReceptors AndrogenComet Assaymedicine.medical_specialtyHepG2AdolescentGlycine[SDV.TOX.TCA]Life Sciences [q-bio]/Toxicology/Toxicology and food chainBiology03 medical and health sciencesAromataseglyphosateInternal medicineCell Line TumorToxicity TestsmedicineEstrogen Receptor betaHumansRNA MessengerCarcinogen030304 developmental biology0105 earth and related environmental sciencesDose-Response Relationship DrugHerbicidesEstrogen Receptor alphaPesticide ResiduesComet assayEndocrinologychemistry13. Climate actionbiology.proteinXenobioticGenotoxicityDNA DamageToxicology
researchProduct

AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC

2019

<b><i>Introduction:</i></b> Androgen receptor variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC) and has shown potential as a predictive biomarker in circulating tumour cells (CTCs) isolated from the bloodstream in terms of a liquid biopsy. Studies have shown that AR-V7 is a potential surrogate for selecting drug classes for systemic treatment by detecting nuclear AR-V7 by immunofluorescence or measuring AR-V7 messenger RNA by quantitative PCR. Here, we assessed the predictive value of AR-V7 detected by classical immunohistochemistry (IHC) for treatment response. <b><i>Methods:</i></b> C…

MaleUrology030232 urology & nephrologyAntineoplastic AgentsDocetaxel03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicineCell Line TumormedicineHumansEnzalutamideProspective StudiesLiquid biopsyAgedAged 80 and overbusiness.industryAndrogen AntagonistsNeoplastic Cells CirculatingPrognosismedicine.diseaseAndrogen receptorProstatic Neoplasms Castration-ResistantTreatment OutcomeDocetaxelchemistryReceptors AndrogenCabazitaxel030220 oncology & carcinogenesisCancer researchBiomarker (medicine)ImmunohistochemistryTaxoidsbusinessmedicine.drugUrologia Internationalis
researchProduct

Immunomodulatory Mechanisms Mediated by Sex Hormones in Rheumatoid Arthritis

1996

Malebusiness.industryGeneral Neurosciencemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyArthritis RheumatoidReceptors EstrogenHistory and Philosophy of ScienceReceptors AndrogenRheumatoid arthritisImmunologyHumansMedicineFemaleGonadal Steroid HormonesbusinessHormoneAnnals of the New York Academy of Sciences
researchProduct

Biochemical selection of prepubertal patients with androgen insensitivity syndrome by sex hormone-binding globulin response to the human chorionic go…

1997

Before puberty, the diagnosis of androgen insensitivity syndrome (AIS) can be difficult. We studied whether the decrease of sex hormone-binding globulin (SHBG) during the human chorionic gonadotropin (hCG) test may represent a biochemical test to select prepubertal patients with AIS. We examined prepubertal patients with AIS (n = 9, age 0.9-8.2 y), male pseudohermaphroditism not due to AIS (other-MPH) (n = 8, age 0.6-10.7 y), and control boys (n = 12, age 0.8-12.5 y). Testosterone and SHBG levels (mean +/- SD) were measured before (d 0) and after (d 5) a hCG test (1500 IU X 3 d). Testosterone levels (nmol/L) increased in all groups [AIS: from 1.5 +/- 1.2 to 22.1 +/- 11.8 (p0.001); other-MPH…

Maleendocrine systemmedicine.medical_specialtyGlobulinmedicine.drug_classDisorders of Sex DevelopmentEndocrine System DiseasesChorionic GonadotropinHuman chorionic gonadotropinSex hormone-binding globulinInternal medicineSex Hormone-Binding GlobulinmedicineHumansTestosteroneChildSelection (genetic algorithm)biologyurogenital systemPatient SelectionInfantSyndromeAndrogenmedicine.diseaseEndocrinologyReceptors AndrogenCase-Control StudiesChild PreschoolKaryotypingembryonic structuresPediatrics Perinatology and Child Healthbiology.proteinAndrogensAndrogen insensitivity syndromeGonadotropinSex Hormone Binding ProteinPediatric research
researchProduct

Testosterone metabolism in patients with advanced carcinoma of the prostate: a comparative in vivo study of the effects of oestrogen and antiprolacti…

1978

In the light of the high incidence of cardiovascular side effects with oestrogen therapy in patients with prostatic cancer, other medications altering androgen metabolism are under investigation. The influence of the anti-prolactin bromocriptine (CB154) on plasma kinetics of testosterone and on endogenous hormones was studied and compared with the effect of ethinyl oestradiol in 25 patients with prostatic carcinoma. Bromocriptine significantly suppressed both prolactin and testosterone, inhibited the transfer of androgen from the inner pool into the deep compartment and favoured its degradation. Ethinyl oestradiol decreased testosterone, LH and FSH, and prolonged the biological half-life of…

Maleendocrine systemmedicine.medical_specialtymedicine.drug_classUrologyProstateInternal medicinemedicineCarcinomaHumansTestosteroneTestosteroneBromocriptineDose-Response Relationship DrugEstradiolbusiness.industryCancerProstatic NeoplasmsLuteinizing HormoneAndrogenmedicine.diseaseProlactinBromocriptineProlactinmedicine.anatomical_structureEndocrinologyReceptors AndrogenFollicle Stimulating Hormonebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugHormoneUrological research
researchProduct

Post-weaning xenohormone intake affects adult rat submandibular gland in a sex-dependent manner

2018

International audience; OBJECTIVES: We previously reported that maternal exposure to genistein, vinclozolin, ingested alone or in combination, affects submandibular salivary glands of rats' offspring's. Here, we investigated the responsiveness of submandibular gland when such xenohormone exposure occurs later in life. MATERIALS AND METHODS: Chemicals were given orally to male and female Wistar rats (1mg/kg body weight per day), from weaning to adulthood. Submandibular glands and plasma were collected at postnatal day 100 for histological and molecular analysis. RESULTS: Whereas no effect was observed in females, increases in granular convoluted tubules area coupled with a modification of sa…

Malemedicine.medical_specialtyOffspringSubmandibular GlandPhytoestrogenssalivary glandWeaning03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSex Factorsstomatognathic systemInternal medicineProgesterone receptormedicineWeaningAnimalsVinclozolinRNA MessengerCystatin CGeneral DentistryOxazolesbiologySalivary glandbusiness.industryMucinsex-dimorphismAndrogen Antagonists030206 dentistryTransforming Growth Factor alphaSubmandibular glandGenisteinRatsEndocrinologymedicine.anatomical_structureendocrine disruptorsepidermal growth factorOtorhinolaryngologyCystatin CchemistryReceptors Androgen030220 oncology & carcinogenesisbiology.proteinFemalebusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy

1991

The main goal of this study was to ascertain whether routine transurethral resection (TUR) of prostate may provide useful material for the evaluation of androgen receptor (AR) status. At the same time, either intracellular distribution of binding affinity and capacity of receptor molecules were particularly taken into account. Based on our previous findings in breast and endometrial cancer, we suggest that a "functional" receptor status may correspond to the presence of type I (high affinity, low capacity) AR in both soluble and nuclear fractions. However, the precise significance of type II (lower affinity, higher capacity) binding sites remains to be clarified. Ten samples of large prosta…

Malemedicine.medical_specialtyReceptor StatusUrologymedicine.medical_treatmentProstatic HyperplasiaUrologySpecimen HandlingRadioligand AssayProstateInternal medicineElectrocoagulationmedicineRadioligandHumansMiboleroneReceptorProstatectomyChemistryEndometrial cancerProstatemedicine.diseaseIn vitroAndrogen receptorEndocrinologymedicine.anatomical_structureReceptors AndrogenUrological Research
researchProduct